Import Alert 54-14 lets FDA detain dietary supplements from listed manufacturers without examining them after a foreign inspection finds the plant does not follow the supplement GMP rule in 21 CFR Part 111. Ayurvedic herbs, collagen, kava, vitamins and herbal teapills are on it. Removal depends on fixing the quality system, not on testing a batch.
Listed on 54-14? Send us the firm name, products and the FDA inspection findings. We plan the corrective actions and the removal request.
Get a 54-14 Case Review| Item | Import Alert 54-14 |
|---|---|
| Official title | DWPE of Dietary Supplement Products From Firms That Have Not Met Dietary Supplement GMP |
| Rule | 21 CFR Part 111 (final rule June 25, 2007, 72 FR 34752) |
| Basis | FDA foreign inspection findings |
| Charge | Section 402(g)(1), refusal under 801(a)(3); code SUPPL GMP |
| Countries | 16 countries on the Red List |
| Removal contact | Importalerts2@fda.hhs.gov |
Details follow the current text of Import Alert 54-14, published September 21, 2026.
Guggul powders, churnas, herbal teas and capsules.
Teapills and herbal tablets.
Collagen drinks, powders and beauty blends.
Kava products and noni juice.
Multivitamins, iron, vitamin C and joint formulas.
Royal jelly, propolis, bee pollen and syrups.
To release a single detained shipment, the owner, consignee or other responsible party sends documentation showing the GMP violations for that product were adequately corrected. The Human Foods Program reviews it. Testing a batch alone does not prove GMP compliance.
Information showing the manufacturer has resolved the GMP conditions behind the listing, with corrective action documentation, emailed to Importalerts2@fda.hhs.gov under RPM Chapter 9-8. FDA may want to reinspect before deciding.
FDA's framework is in RPM Chapter 9-8; FDA removal guidance explains what a request should include.
Removal help for food and supplements.
Supplement registration and labeling.
Supplements with hidden drugs.
Heavy metals in herbal products.
Check claims and ingredient labeling.
FDA hold statuses and release steps.
We review the inspection findings, plan the GMP corrective actions and prepare the removal request. We are an independent compliance firm, not FDA or a law firm, and no one can guarantee FDA's decision.
Contact our specialists, email info@fdaregistrationassistance.com, or call +1 (928) 275-8333. Import alert removal · Supplement services · Contact.
Get a 54-14 Case ReviewFDA Registration Assistance is a private consulting firm, not FDA or any government agency. FDA registration is not FDA approval, clearance or certification.
Import Alert 54-14 is titled "Detention Without Physical Examination of Dietary Supplement Products From Firms That Have Not Met Dietary Supplement GMP." It lets FDA detain listed supplements, bulk or finished, without examining each shipment.
21 CFR Part 111, the dietary supplement current good manufacturing practice rule, published June 25, 2007. It sets minimum requirements for manufacturing, packaging, labeling and holding supplements, and it applies to supplements imported or offered for import.
When FDA inspects a foreign supplement manufacturer and the findings show its products were not made in conformity with current GMP. Listings come from inspection findings, not from testing a shipment.
The supplement appears to have been prepared, packed or held under conditions that do not meet current GMP, making it adulterated under section 402(g)(1) and subject to refusal under section 801(a)(3). The OASIS code is SUPPL GMP.
Ayurvedic herbal products, Chinese herbal teapills and tablets, collagen and beauty supplements, kava and noni products, vitamins and minerals, and bee products such as royal jelly and propolis. Some firms are listed for all of their dietary supplement products.
The Red List covers 16 countries, including Canada, India, Mexico, China, Japan, Germany, Fiji, Spain and the United Kingdom. Canada, India and Mexico have multiple firms listed.
Open Import Alert 54-14 and search the Red List by country and firm name. Each entry shows the product and the date it was added. Check before every shipment season, since the alert is updated often.
Yes, case by case. The owner, consignee or other responsible party sends documentation showing the GMP violations for that product were adequately corrected, and FDA's Human Foods Program reviews it. Contact the FDA Division compliance office named in the notice.
Not by itself. The problem is how the product was made, so a passing test on one batch does not show GMP compliance. Test results can support a corrective action package, but they do not replace it.
Show FDA that the manufacturer has resolved the conditions behind the violation, with corrective action documentation, and email it to Importalerts2@fda.hhs.gov. FDA's framework is in RPM Chapter 9-8.
Often. The alert does not require it, but because listings come from inspections, FDA may want to verify the corrections with a new inspection before it removes the firm.
Missing specifications, no identity testing of dietary ingredients, incomplete master manufacturing and batch records, weak quality control review, and poor complaint and record handling.
Removal petitions go to Importalerts2@fda.hhs.gov. The alert lists the Division of Import Operations at (301) 796-0356 or Imports@fda.hhs.gov, and HFP-OCE-Imports@fda.hhs.gov for policy questions not tied to a detained entry.
Yes. We help organize the corrective actions, SOPs and records FDA will ask to see. See our dietary supplement services. We are not a certification body and do not issue GMP certificates.
No. FDA makes every removal decision. We are an independent compliance firm, not FDA or a law firm. We help you build a complete, well-documented request.
Tell us what your company makes, sells, or distributes, where each product is manufactured or packed, your U.S. importer or buyer arrangement, label readiness, and target shipment date.
Submitting this inquiry does not purchase a service or authorize paid work. Our team can discuss the scope and required materials before you commission assistance. Fields marked with an asterisk are required.